Factdock Insights

Medicine & pharma

Human medicine: approvals, safety communications and the trials and disclosures behind them.

Share
Updated · 2026-10-29 22:10 UTC38
Global trending keyword rankingSee the full ranking for all fieldsClose

The topics people around the world are reading most on Wikipedia right now, by field. Updated daily.

Global ranking: page views from every language edition of Wikipedia are added together, one day at a time. Top 5 in each field.

Wikipedia page views · Oct 29, 2026

Medicine & pharmaRising today
  1. Lewy body dementia166.9K views+7,254%New
  2. Dementia with Lewy bodies35.4K views+1,603%New
  3. Fraser syndrome1.8K views+2,692%New
  4. Alzheimer's disease35.5K views+759%New
  5. Parkinson's disease dementia1.4K views+1,420%New
Animal healthRising today
  1. Chronic wasting disease2.6K views+122%New
  2. Deer cutaneous fibroma182 views+528%New
  3. Laminitis584 views+68%New
  4. Yellow fever1.9K views+38%New
  1. Acetamiprid506 views+256%New
  2. Rodenticide841 views+92%New
  3. Cyclamate412 views+51%
  4. Neotame160 views+111%
  1. Lunar Orbiter 15K views+11,836%
  2. Galileo (spacecraft)4.1K views+1,310%New
  3. Lunar Orbiter 2600 views+3,233%New
  4. STS-95718 views+698%New
Cyber & data rulesRising today
  1. Stagefright (bug)404 views+1,396%New
  2. Lazarus Group2.1K views+166%New
  3. Volt Typhoon302 views+167%
  4. ShinyHunters887 views+35%New
Disclosures & M&ARising today
  1. ServiceNow7.4K views+829%New
  2. Instacart5.6K views+835%New
  3. European Central Bank5.6K views+470%New
  4. Binance7.1K views+455%New
  5. Baker McKenzie1.4K views+665%New

Members can see the top 30, weekly trends and a ranking for each language.

Ranked by Wikipedia page views from human readers. Page views show how much attention a topic is getting, not its importance or accuracy. Source: Wikimedia Foundation (CC0).

Today’s lead story

PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results

– Strong Q3 2026 performance with total revenue of $358 million, including $276 million of product revenue – – Full-year 2026 expected total revenue increased to $1.29 to $1.32 billion, with full-year product revenue guidance raised to $960 to $990 million – – Sephience™ (sepiapterin) Q3...

Medicine & pharmaPipeline & developmentPR Newswire (Health)
Read the source
Medicine & pharmaPipeline & developmentPR Newswire (Biotechnology)

Entangled 2026 Summit Unites Leaders in Quantum Computing, AI and Biotech to Explore What Makes the Next Life Sciences Breakthrough Possible

LabCentral, C10 Labs and Innovation Centre Denmark Boston host cross-sector event to examine how emerging technologies and human collaboration could shape the next wave of scientific discovery CAMBRIDGE, Mass., Oct. 29, 2026 /PRNewswire/ -- LabCentral, C10 Labs and Innovation Centre...

Read the source
Medicine & pharmaPipeline & developmentPR Newswire (Clinical Trials)

Laplace Interventional™ Announces First Patients treated in TRIUMPH Pivotal Trial with its Transcatheter Tricuspid Valve Replacement System

PLYMOUTH, Minn., Oct. 29, 2026 /PRNewswire/ -- Minnesota based Laplace Interventional today announced that the first three patients have been enrolled and treated in the randomized cohort of their TRIUMPH pivotal trial. These patients were treated at Ballad Health (Kingsport, TN) and...

Read the source

Official intelligence

Confirmed rules and announcements from government bodies, regulators and official journals.

Medicine & pharmaNAFDACNG

NAFDAC stops accepting new registration applications for imported pharmaceuticals

The National Agency for Food and Drug Administration and Control (NAFDAC) has updated its Ceiling List to stop accepting new registration applications for imported pharmaceutical products. Renewal applications will be processed under the 5+5 policy pathway, requiring applicants to submit a blueprint for local manufacturing capabilities.

Read the source

Read every record in your own language

This page shows the three newest items per field. Members see every record in the field, in 109 languages, with the search engines that work on them.

Read it in full for $29

No app-store installation. Cancel any time.

The latest in each field

Every item links to the institution that published it. Nothing is rewritten without its source.